Shopping Cart
- Remove All
- Your shopping cart is currently empty
UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 332 € | In Stock | |
5 mg | 786 € | In Stock | |
10 mg | 1.073 € | In Stock | |
25 mg | 1.510 € | In Stock | |
50 mg | 1.881 € | In Stock | |
100 mg | 2.375 € | In Stock | |
500 mg | 4.655 € | In Stock | |
1 mL x 10 mM (in DMSO) | 680 € | In Stock |
Description | UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment. |
In vivo | After i.v. administration of UK-240455 to male rats, UK-240455 exhibits a clearance of 12 mL/min/kg and a volume of distribution of 0.4 L/kg. The plasma concentration of UK-240455 shows a decrease with an apparent half-life of 0.4 h. The analysis of urine (0 to 24 h) reveals that 57% of the administered dose is excreted unchanged. Thus, the urine clearance rate of UK-240455 in rats amounts to 7 mL/min/kg. Upon oral administration to male rats, the apparent elimination half-life of UK-240455 from plasma was observed to be 1.6 hours.[1] |
Molecular Weight | 368.19 |
Formula | C11H11Cl2N3O5S |
Cas No. | 178908-09-3 |
Smiles | N(CCO)(S(C)(=O)=O)C1=C2C(=CC(Cl)=C1Cl)NC(=O)C(=O)N2 |
Relative Density. | 1.686 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 12 mg/mL (32.59 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.